ZÍTKA, Ondřej, Jiří KUKAČKA, Soňa KŘÍŽKOVÁ, Dalibor HÚSKA, Vojtěch ADAM, Michal MASAŘÍK, Richard PRŮŠA and René KIZEK. Matrix metalloproteinases. Current Medicinal Chemistry. 2010, vol. 17, No 31, 18 pp. ISSN 0929-8673.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Matrix metalloproteinases.
Authors ZÍTKA, Ondřej (203 Czech Republic, belonging to the institution), Jiří KUKAČKA (203 Czech Republic), Soňa KŘÍŽKOVÁ (203 Czech Republic, belonging to the institution), Dalibor HÚSKA (203 Czech Republic), Vojtěch ADAM (203 Czech Republic, belonging to the institution), Michal MASAŘÍK (203 Czech Republic, guarantor), Richard PRŮŠA (203 Czech Republic) and René KIZEK (203 Czech Republic, belonging to the institution).
Edition Current Medicinal Chemistry, 2010, 0929-8673.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Arab Emirates
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.630
RIV identification code RIV/00216224:14110/10:00040657
Organization unit Faculty of Medicine
UT WoS 000284714300011
Keywords in English matrix metalloproteinases; collagen; tissue inhibitors of matrix metalloproteinases; cysteine switch; zinc; metallothionein; tumour disease
Changed by Changed by: prof. RNDr. Michal Masařík, Ph.D., učo 21142. Changed: 21/1/2011 10:14.
Abstract
Matrix metalloproteinases (MMPs), also known as matrixins, belong to a group of zinc-dependent proteins, which are thought to play a central role in the breakdown of extracellular matrix. Collagen, elastin, gelatine and casein are major components cleaved by MMPs. The breakdown of these components is essential for many physiological processes such as embryonic development, morphogenesis, reproduction, and tissue resorption and remodelling. MMPs also participate in pathological processes such as arthritis, cancer, cardiovascular and neurological diseases. This review summarizes current knowledge regarding these proteins, their participation in physiological and pathophysiological roles, their involvement in activation and inhibition, and their interactions with other metal-binding proteins including metallothioneins.
Links
GP301/09/P436, research and development projectName: Analýza metalothioneinu u karcinomu prostaty na úrovni DNA, RNA a proteinu.
Investor: Czech Science Foundation
IAA401990701, research and development projectName: Studium vazby platinových cytostatik do struktury DNA; Vliv metalothioneinu
NS10200, research and development projectName: Nádorové markery, jejich stanovení a korelace s karcinomem prostaty
Investor: Ministry of Health of the CR
PrintDisplayed: 29/7/2024 22:01